The emerging role and targetability of the TCA cycle in cancer metabolism

NM Anderson, P Mucka, JG Kern, H Feng - Protein & cell, 2018 - academic.oup.com
The tricarboxylic acid (TCA) cycle is a central route for oxidative phosphorylation in cells,
and fulfills their bioenergetic, biosynthetic, and redox balance requirements. Despite early …

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies

E Molinaro, C Romei, A Biagini, E Sabini… - Nature Reviews …, 2017 - nature.com
Anaplastic thyroid carcinoma (ATC) is a rare malignancy, accounting for 1–2% of all thyroid
cancers. Although rare, ATC accounts for the majority of deaths from thyroid carcinoma. ATC …

Molecular pathogenesis and mechanisms of thyroid cancer

M Xing - Nature Reviews Cancer, 2013 - nature.com
Thyroid cancer is a common endocrine malignancy. There has been exciting progress in
understanding its molecular pathogenesis in recent years, as best exemplified by the …

Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors

M Xiao, H Yang, W Xu, S Ma, H Lin, H Zhu… - Genes & …, 2012 - genesdev.cshlp.org
Two Krebs cycle genes, fumarate hydratase (FH) and succinate dehydrogenase (SDH), are
mutated in a subset of human cancers, leading to accumulation of their substrates, fumarate …

Marked for death: targeting epigenetic changes in cancer

SX Pfister, A Ashworth - Nature reviews Drug discovery, 2017 - nature.com
In the past few years, it has become clear that mutations in epigenetic regulatory genes are
common in human cancers. Therapeutic strategies are now being developed to target …

Cancer development, progression, and therapy: an epigenetic overview

S Sarkar, G Horn, K Moulton, A Oza, S Byler… - International journal of …, 2013 - mdpi.com
Carcinogenesis involves uncontrolled cell growth, which follows the activation of oncogenes
and/or the deactivation of tumor suppression genes. Metastasis requires down-regulation of …

IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives

H Yang, D Ye, KL Guan, Y Xiong - Clinical cancer research, 2012 - AACR
Genes encoding for isocitrate dehydrogenases 1 and 2, IDH1 and IDH2, are frequently
mutated in multiple types of human cancer. Mutations targeting IDH1 and IDH2 result in …

Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation

H Yang, Y Liu, F Bai, JY Zhang, SH Ma, J Liu, ZD Xu… - Oncogene, 2013 - nature.com
The TET (ten–eleven translocation) family of α-ketoglutarate (α-KG)-dependent
dioxygenases catalyzes the sequential oxidation of 5-methylcytosine (5mC) to 5 …

Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

TC Pansuriya, R van Eijk, P d'Adamo… - Nature …, 2011 - nature.com
Ollier disease and Maffucci syndrome are non-hereditary skeletal disorders characterized by
multiple enchondromas (Ollier disease) combined with spindle cell hemangiomas (Maffucci …

TET proteins and the control of cytosine demethylation in cancer

L Scourzic, E Mouly, OA Bernard - Genome medicine, 2015 - Springer
The discovery that ten-eleven translocation (TET) proteins are α-ketoglutarate-dependent
dioxygenases involved in the conversion of 5-methylcytosines (5-mC) to 5 …